Clinical Trial Update: Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants [NA]

View source ↗

Summary

A completed clinical trial comparing zoledronic acid to alendronate for bone loss after kidney and kidney/pancreas transplants; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant-related Bone Loss
• Renal Insufficiency

Drugs mentioned

• Zoledronic acid (Zoledronic acid)
• alendronate (alendronate)

Snippet

Sponsor: University of Nebraska | Conditions: Renal Insufficiency | NA | Status: COMPLETED | Results posted: 2018-03-19